These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 2905508)
1. Psychobiologic aspects of the treatment of primary mania. Clower CG Psychiatr Med; 1988; 6(3):83-91. PubMed ID: 2905508 [No Abstract] [Full Text] [Related]
2. Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder. Goodwin FK J Clin Psychiatry; 2003; 64 Suppl 5():18-24. PubMed ID: 12720480 [TBL] [Abstract][Full Text] [Related]
4. Neuroleptic exposure in bipolar outpatients in a research setting. Denicoff KD; Sollinger AB; Frye MA; Ali SO; Smith-Jackson EE; Leverich GS; Post RM Compr Psychiatry; 2000; 41(4):248-52. PubMed ID: 10929791 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic and prophylactic effects of carbamazepine in bipolar disorders. Okuma T Psychiatr Clin North Am; 1983 Mar; 6(1):157-74. PubMed ID: 6351033 [TBL] [Abstract][Full Text] [Related]
6. The relationship between antimanic agent for treatment of classic or dysphoric mania and length of hospital stay. Frye MA; Altshuler LL; Szuba MP; Finch NN; Mintz J J Clin Psychiatry; 1996 Jan; 57(1):17-21. PubMed ID: 8543542 [TBL] [Abstract][Full Text] [Related]
7. Rational polypharmacy in the bipolar affective disorders. Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735 [TBL] [Abstract][Full Text] [Related]
8. Approaches to the treatment of lithium-resistant mania. Menza MA; Easton J; Flaum MA; Frank DL; Goldberg IC; Michell MY Psychiatr Med; 1988; 6(4):73-87. PubMed ID: 2907168 [No Abstract] [Full Text] [Related]
9. Carbamazepine treatment of mania: clinical and biochemical aspects. Post R; Uhde T; Kramlinger K; Rubinow D Clin Neuropharmacol; 1986; 9 Suppl 4():547-9. PubMed ID: 3567962 [No Abstract] [Full Text] [Related]
10. Carbamazepine versus lithium in mania: a double-blind study. Lerer B; Moore N; Meyendorff E; Cho SR; Gershon S J Clin Psychiatry; 1987 Mar; 48(3):89-93. PubMed ID: 3546274 [TBL] [Abstract][Full Text] [Related]
11. Health-economic implications of the onset of action of antimanic agents. Keck PE; McElroy SL; Bennett JA J Clin Psychiatry; 1996; 57 Suppl 13():13-8; discussion 19-22. PubMed ID: 8970501 [TBL] [Abstract][Full Text] [Related]
13. [Has drug treatment of manic disorders changed in clinical routine practice? Retrospective analysis of treatment modalities and results in a university psychiatric clinic]. Reetz-Kokott U; Müller-Oerlinghausen B Nervenarzt; 1996 Mar; 67(3):229-34. PubMed ID: 8901281 [TBL] [Abstract][Full Text] [Related]
14. A medication algorithm for treatment of bipolar rapid cycling? Calabrese JR; Woyshville MJ J Clin Psychiatry; 1995; 56 Suppl 3():11-8. PubMed ID: 7883737 [TBL] [Abstract][Full Text] [Related]
15. Valproate in bipolar disorder: the Canadian perspective. Joffe RT Can J Psychiatry; 1993 Apr; 38(3 Suppl 2):S46-50. PubMed ID: 8098990 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of lithium in mania and maintenance therapy of bipolar disorder. Bowden CL J Clin Psychiatry; 2000; 61 Suppl 9():35-40. PubMed ID: 10826659 [TBL] [Abstract][Full Text] [Related]
17. [Pharmacotherapy of depression in patients with and without conversion from depression to mania in the course of bipolar affective disorder]. Koszewska I Psychiatr Pol; 1996; 30(1):99-111. PubMed ID: 8722243 [TBL] [Abstract][Full Text] [Related]
18. Carbamazepine and valproate in the maintenance treatment of bipolar disorder. Keck PE; McElroy SL J Clin Psychiatry; 2002; 63 Suppl 10():13-7. PubMed ID: 12392348 [TBL] [Abstract][Full Text] [Related]